Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Nutrients
|
June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy
Hedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
JAMA Network Open
|
April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care Centers
Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
The Oncologist
|
March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
Luis Meza, Zeynep Zengin, Sabrina Salgia, et al.
Journal for Immunotherapy of Cancer
|
May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma
Ameish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.
Cancer Investigation
|
October 14, 2022
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study
Daniela V Castro, Zeynep B Zengin, Jasnoor Malhotra, et al.
The Oncologist
|
January 17, 2025
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, et al.
Nature Medicine
|
March 1, 2022
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman, Luis Meza, Paulo Bergerot, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
Hedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, et al.
European Urology Oncology
|
January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
Zeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Nutrients
|
June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy
Hedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
JAMA Network Open
|
April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care Centers
Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
The Oncologist
|
March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
Luis Meza, Zeynep Zengin, Sabrina Salgia, et al.
Journal for Immunotherapy of Cancer
|
May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma
Ameish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.
Cancer Investigation
|
October 14, 2022
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study
Daniela V Castro, Zeynep B Zengin, Jasnoor Malhotra, et al.
The Oncologist
|
January 17, 2025
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, et al.
Nature Medicine
|
March 1, 2022
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman, Luis Meza, Paulo Bergerot, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
Hedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, et al.
European Urology Oncology
|
January 7, 2023
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
Zeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Page
of 2